This is the authors' abstract. We don't add key points for this paper.
Switching cyclophosphamide to azathioprine after induction of remission in patients with PR3-ANCA-associated vasculitis who are still ANCA-positive at the time of treatment switch is associated with a high risk of relapse.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Slot et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: